Quest Laboratories Limited
Book Built Issue IPO · NSE
- Price band
- ₹93 - ₹97
- Lot size
- 1,200 shares
- Issue amount
- ₹43.16 cr
- Total subscription
- 85.34×
- Opens
- 15 May 2024
- Closes
- 17 May 2024
- Allotment
- 21 May 2024
- Listing
- 23 May 2024
Offer at a glance
Issue overview
- Issue size
- 44,49,600 shares
- Face value
- ₹10 Per Equity Share
- Minimum investment
- ₹1,11,600
- Fresh issue
- ₹43.16 cr
- Offer for sale
- ₹0 cr
- Registrar
- Bigshare Services Private Limited
- Listing exchange
- NSE
- Maximum investment
- ₹1,16,400
- Issue type
- Book Built Issue IPO
- Shares before issue
- 1,19,37,600
- Shares after issue
- 1,63,87,200
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 1,200 | ₹1,16,400 |
| HNI | 2 | 2,400 | ₹2,32,800 |
Share reservation
Subscription & GMP
Subscription by category
Missing multiples are calculated from bids and offered shares when available.
GMP history
Subscription demand
Amounts in ₹ crore. HNI subcategories are included in the NII total.
| Category | Offered | Demand |
|---|---|---|
| QIBs | 8.07 | 461.44 |
| RETAIL | 14.54 | 837.79 |
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Key performance indicators
| Metric | Dec-23 | Mar-23 | Mar-22 |
|---|---|---|---|
| EPS | 7.18 | 4.66 | 3.81 |
| ROE | 34.03 | 40.2 | 51.69 |
| ROCE | 0 | 0 | 0 |
| RONW | 34.03 | 33.47 | 41.08 |
| PRE IPO(PE) | 4.59 | 0 | 0 |
| POST IPO(PE) | 23.03 | 0 | 0 |
Values and labels as reported in the issue data.
Company information
Company profile
Founded in June 1998, Quest Laboratories Limited is a well-known pharmaceutical company that produces a wide range of medicines, including antibiotics, antimalarials, pain relievers, respiratory treatments, diabetes medications, and antidepressants. The company operates across 12 states and 2 union territories in India, including Uttar Pradesh, Maharashtra, Delhi, Karnataka, and more. Headquartered in Dhar, Madhya Pradesh, Quest Laboratories runs advanced manufacturing facilities that meet strict international quality standards like WHO GMP, GLP, and ISO certifications. With a skilled team of 83 professionals handling production, quality control, engineering, inventory, and administration, the company is dedicated to maintaining top-quality standards and delivering reliable medical solutions.
Strengths
- Wide Product Range: The company offers a variety of medicines for different health needs, making it adaptable to market changes and creating more opportunities for growth.
- Trusted by Government Institutions: Working with government institutions shows the company’s strong reputation and reliability, ensuring stable and long-term financial success.
- Strong Product Portfolio: Covering multiple medical fields, the company stays competitive, expands its market reach, and remains a key player in the pharmaceutical industry.
Risk factors
- Legal Challenges: Ongoing legal cases could affect the company’s business, reputation, and financial health. Negative outcomes, especially those involving the promoter, may lead to disruptions and financial risks.
- Promoter’s Legal Issues: The promoter’s legal troubles, including imprisonment and appeals, create uncertainty about the company’s future. Any unfavorable rulings could impact operations and stability.
- Quality Control Risks: Issues in manufacturing or product quality could harm the company’s reputation, leading to legal troubles, regulatory fines, and financial setbacks. Maintaining high standards is crucial for market trust and long-term success.
Promoters
Mr. Anil Kumar Sabarwal
Ms. Tejaswini Sabarwal
Registrar & documents
Lead manager
Shreni Shares Limited
Registrar & contacts
Bigshare Services Private Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
Plot No. 45, Sector III, Pithampur Industrial Area, Pithampur, Dhar - 454775
07292292374
[email protected]Company website ↗Understanding QUESTLAB IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.